GeneDx Holdings Price to Book Ratio 2020-2024 | WGS
Historical price to book ratio values for GeneDx Holdings (WGS) over the last 10 years. The current price to book ratio for GeneDx Holdings as of January 06, 2025 is 10.70.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
GeneDx Holdings Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-01-03 | 79.14 | 10.62 | |
2024-09-30 | 42.44 | $7.45 | 5.69 |
2024-06-30 | 26.14 | $7.21 | 3.63 |
2024-03-31 | 9.13 | $7.93 | 1.15 |
2023-12-31 | 2.75 | $8.78 | 0.31 |
2023-09-30 | 3.64 | $9.83 | 0.37 |
2023-06-30 | 5.96 | $11.49 | 0.52 |
2023-03-31 | 0.37 | $13.58 | 0.03 |
2022-12-31 | 0.26 | $21.55 | 0.01 |
2022-09-30 | 0.88 | $48.57 | 0.02 |
2022-06-30 | 1.26 | $55.36 | 0.02 |
2022-03-31 | 3.07 | $44.35 | 0.07 |
2021-12-31 | 4.46 | $52.79 | 0.08 |
2021-09-30 | 7.59 | $53.76 | 0.14 |
2021-06-30 | 14.01 | $6.72 | 2.09 |
2021-03-31 | 14.89 | $6.38 | 2.33 |
2020-12-31 | 10.35 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $2.188B | $0.203B |
GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $84.844B | 10.53 |
Cencora (COR) | United States | $43.438B | 16.33 |
DiDi Global (DIDIY) | China | $22.990B | 0.00 |
Natera (NTRA) | United States | $21.203B | 0.00 |
ICON (ICLR) | Ireland | $17.541B | 15.62 |
Viatris (VTRS) | United States | $14.824B | 4.57 |
Avantor (AVTR) | United States | $14.429B | 21.63 |
Revvity (RVTY) | United States | $13.631B | 23.68 |
BioMerieux (BMXMF) | France | $12.250B | 0.00 |
CochLear (CHEOY) | Australia | $11.924B | 0.00 |
Solventum (SOLV) | United States | $11.390B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.405B | 29.31 |
Doximity (DOCS) | United States | $9.999B | 58.86 |
Charles River Laboratories (CRL) | United States | $9.340B | 18.05 |
HealthEquity (HQY) | United States | $8.390B | 42.09 |
Sonic Healthcare (SKHHY) | Australia | $8.095B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.339B | 29.51 |
Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
Sotera Health (SHC) | United States | $3.858B | 20.64 |
Organon (OGN) | United States | $3.853B | 3.89 |
BrightSpring Health Services (BTSG) | United States | $3.018B | 64.18 |
Surgery Partners (SGRY) | United States | $2.706B | 30.85 |
Concentras Parent (CON) | United States | $2.456B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.405B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.216B | 0.00 |
Premier (PINC) | United States | $2.054B | 10.69 |
PACS (PACS) | United States | $1.971B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.738B | 45.60 |
Ryman Healthcare (RYHTY) | New Zealand | $1.720B | 0.00 |
Teladoc Health (TDOC) | United States | $1.639B | 0.00 |
Progyny (PGNY) | United States | $1.510B | 30.57 |
Establishment Labs Holdings (ESTA) | $1.268B | 0.00 | |
Embecta (EMBC) | United States | $1.177B | 8.23 |
CareDx (CDNA) | United States | $1.154B | 0.00 |
Pediatrix Medical (MD) | United States | $1.119B | 10.95 |
AMN Healthcare Services Inc (AMN) | United States | $0.935B | 6.33 |
Agilon Health (AGL) | United States | $0.791B | 0.00 |
SBC Medicals (SBC) | United States | $0.572B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.566B | 14.81 |
InnovAge Holding (INNV) | United States | $0.534B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
DocGo (DCGO) | United States | $0.438B | 16.50 |
Sonida Senior Living (SNDA) | United States | $0.436B | 0.00 |
Enhabit (EHAB) | United States | $0.390B | 33.70 |
COMPASS Pathways (CMPS) | United Kingdom | $0.284B | 0.00 |
Sera Prognostics (SERA) | United States | $0.281B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.237B | 0.00 |
LifeMD (LFMD) | United States | $0.227B | 0.00 |
Biodesix (BDSX) | United States | $0.215B | 0.00 |
MultiPlan (MPLN) | United States | $0.209B | 0.00 |
Beauty Health (SKIN) | United States | $0.200B | 0.00 |
Nutex Health (NUTX) | United States | $0.189B | 0.00 |
ModivCare (MODV) | United States | $0.177B | 9.60 |
So-Young (SY) | China | $0.097B | 16.41 |
Ascend Wellness Holdings (AAWH) | United States | $0.093B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
OncoCyte (OCX) | United States | $0.039B | 0.00 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
Oncology Institute (TOI) | United States | $0.022B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
KindlyMD (KDLY) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |